Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
- PMID: 15541237
- DOI: 10.1016/j.amjcard.2004.07.106
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
Abstract
This study tested the combination of vascular brachytherapy (VBT) and self-expanding Wallstent implantation in coronary lesions of patients at high risk for restenosis as assessed angiographically by quantitative coronary analysis and by 3-dimensional intravascular ultrasound analysis. Twenty-nine "de novo" lesions were managed with a self-expanding stent alone (n = 19) or with a self-expanding stent after beta-VBT (n = 10) in 27 patients who had been identified by high levels of plasma angiotensin-converting enzyme as being prone to myointimal growth after stent implantation. At 6 months, the increase in stent strut diameter was similar in the 2 groups by quantitative coronary analysis and 3-dimensional intravascular ultrasound (Delta mean stent strut diameter -0.33 +/- 0.3 vs -0.40 +/- 0.3 mm, p = 0.5; Delta stent area -11.8 +/- 6.1 vs -12.0 +/- 6.1 mm(2), p = 0.9; Delta stent volume -96.9 +/- 112 vs -83.5 +/- 73 mm(3), p = 0.7; for groups treated with VBT and self-expanding stents and only self-expanding stents, respectively). In-stent neointimal proliferation was decreased in the group treated with VBT and self-expanding stents (minimal luminal diameter 2.5 +/- 0.8 vs 1.88 +/- 0.8 mm, p = 0.04) by quantitative coronary analysis (minimal luminal area 6.7 +/- 2.5 vs 4.1 +/- 1.9 mm(2), p = 0.01), by intravascular ultrasound, and proliferation volume (84.6 +/- 66.4 vs 159.2 +/- 103.5 mm(3), p = 0.05) by 3-dimensional intravascular ultrasound. Positive vessel and luminal remodelings were observed in 50% of the group treated with VBT and self-expanding stents and in 11% of the group treated only with self-expanding stents (p = 0.02). The combined use of VBT and self-expanding stents is a novel approach that enlarges vascular lumen by preventing vessel constriction and neointimal proliferation. The feasibility and good results of this experimental approach suggest that the simultaneous use of these 2 technologies may be an interesting alternative for difficult vascular districts with high restenosis rates, such as peripheral circulation in the lower limbs.
Similar articles
-
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial.Cardiovasc Revasc Med. 2005 Jan-Mar;6(1):7-13. doi: 10.1016/j.carrev.2005.02.005. Cardiovasc Revasc Med. 2005. PMID: 16263350 Clinical Trial.
-
High-dose intracoronary irradiation after de novo stent implantation results of the EVEREST (Evaluation of Endoluminal Radiation in Elective Stenting) trial.Strahlenther Onkol. 2006 Jan;182(1):9-15. doi: 10.1007/s00066-006-1434-y. Strahlenther Onkol. 2006. PMID: 16404515 Clinical Trial.
-
A randomised trial of endoluminal reconstruction comparing the NIR stent and the Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL Study.Am Heart J. 2001 Jun;141(6):971-6. doi: 10.1067/mhj.2001.115301. Am Heart J. 2001. PMID: 11376312 Clinical Trial.
-
Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.Am Heart J. 2003 Nov;146(5):775-86. doi: 10.1016/S0002-8703(03)00389-2. Am Heart J. 2003. PMID: 14597925 Review.
-
[Clinical, angiographic, and procedure factors predicting coronary restenosis after stent implantation: synthesis of the evidence].Ital Heart J Suppl. 2001 Jul;2(7):719-32. Ital Heart J Suppl. 2001. PMID: 11508290 Review. Italian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources